Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 29, Issue 12, 2011, Pages 1556-1563

  Krebs, Matthew G ^a,b,c,d,e,f   Sloane, Robert ^a,b,c,d,e,f   Priest, Lynsey ^a,b,c,d,e,f   Lancashire, Lee ^a,b,c,d,e,f   Hou, Jian Mei ^a,b,c,d,e,f   Greystoke, Alastair ^a,b,c,d,e,f   Ward, Tim H ^a,b,c,d,e,f   Ferraldeschi, Roberta ^a,b,c,d,e,f   Hughes, Andrew ^a,b,c,d,e,f   Clack, Glen ^a,b,c,d,e,f   Ranson, Malcolm ^a,b,c,d,e,f   Dive, Caroline ^a,b,c,d,e,f   Blackhall, Fiona H ^a,b,c,d,e,f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Christie National Health Service Foundation Trust   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d University of Manchester   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CANCER SURVIVAL; CELL ADHESION; EPITHELIUM CELL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; DISEASE-FREE SURVIVAL; ENGLAND; FEMALE; HUMANS; IMMUNOMAGNETIC SEPARATION; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 79955045007     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.28.7045     Document Type: Article

References (24)

1. Ries L, Eisner M, Kosary C, et al (eds): Cancer Statistics Review, 1975-2002. Bethesda, MD, National Cancer Institute, 2005
2. Mok TS, Wu YL, Thongprasert S, et al: Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361:947-957, 2009
3. Paterlini-Brechot P, Benali NL: Circulating tumor cells (CTC) detection: Clinical impact and future directions. Cancer Lett 253:180-204, 2007 (Pubitemid 47017533)
4. Allard WJ, Matera J, Miller MC, et al: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904, 2004 (Pubitemid 39383039)
5. Cristofanilli M, Budd GT, Ellis MJ, et al: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-791, 2004 (Pubitemid 39095313)
6. Cristofanilli M, Hayes DF, Budd GT, et al: Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23:1420-1430, 2005
7. Hayes DF, Cristofanilli M, Budd GT, et al: Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12:4218-4224, 2006
8. Budd GT, Cristofanilli M, Ellis MJ, et al: Circulating tumor cells versus imaging: Predicting overall survival in metastatic breast cancer. Clin Cancer Res 12:6403-6409, 2006 (Pubitemid 44799711)
9. Cohen SJ, Punt CJ, Iannotti N, et al: Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26:3213-3221, 2008
10. Cohen SJ, Punt CJ, Iannotti N, et al: Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 20: 1223-1229, 2009
11. de Bono JS, Scher HI, Montgomery RB, et al: Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14:6302-6309, 2008
12. Danila DC, Heller G, Gignac GA, et al: Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 13:7053-7058, 2007 (Pubitemid 350276887)
13. Hou JM, Greystoke A, Lancashire L, et al: Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol 175:808-816, 2009
14. Riethdorf S, Fritsche H, Müller V, et al: Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system. Clin Cancer Res 13:920-928, 2007 (Pubitemid 46340368)
15. McShane LM, Altman DG, Sauerbrei W, et al: REporting recommendations for tumour MARKer prognostic studies (REMARK). Eur J Cancer 41: 1690-1696, 2005 (Pubitemid 41132629)
16. Miller MC, Doyle GV, Terstappen LW: Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncol 2010:617421, 2010
17. Tibbe AG, Miller MC, Terstappen LW: Statistical considerations for enumeration of circulating tumor cells. Cytometry A 71:154-162, 2007 (Pubitemid 46355340)
18. Allan AL, Keeney M: Circulating tumor cell analysis: Technical and statistical considerations for application to the clinic. J Oncol 2010:426218, 2010
19. Martín M, García-Sáenz JA, Maestro De las Casas ML, et al: Circulating tumor cells in metastatic breast cancer: Timing of blood extraction for analysis. Anticancer Res 29:4185-4187, 2009
20. Mandrekar SJ, Qi Y, Hillman SL, et al: Endpoints in phase II trials for advanced non-small cell lung cancer. J Thorac Oncol 5:3-9, 2010
21. Tan DS, Thomas GV, Garrett MD, et al: Biomarker-driven early clinical trials in oncology: A paradigm shift in drug development. Cancer J 15: 406-420, 2009
22. Nagrath S, Sequist LV, Maheswaran S, et al: Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235-1239, 2007
23. Wu C, Hao H, Li L, et al: Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients. J Thorac Oncol 4:30-36, 2009
24. Maheswaran S, Sequist LV, Nagrath S, et al: Detection of mutations in EGFR in circulating lungcancer cells. N Engl J Med 359:366-377, 2008